InvestorsHub Logo
icon url

PhenixBleu

05/18/18 8:49 PM

#37412 RE: SchlumpyStock-Picker #37405

The Disclosure statement confirms exactly what I've been saying all along. The receivable is owed to VDRM by its CEO through his Podiatry practice Coast to Coast. Otiko and Coast to Coast are subjects of a copyright infringement lawsuit (Josten Theney). Otiko and Coast to Coast were subjects of a trademark infringement lawsuit. How can Otiko pay his debt to VDRM when Coast to Coast is dirt poor and indebted to attorneys?

Otiko bought a product from ViaDerma years ago through Coast to Coast totalling ~350k. He hasn't paid a penny of that amount. Look how far back that receivable goes. What product was VDRM selling at that time? Was it the product trademarked by Keough? Did Coast to Coast sell those products? If not, are they sitting on a shelf in his rathole Reseda business? If he sold them through C to C, why isn't he turning the sales over to ViaDerma?

Otiko also owns BioGenx. The distributors named by VDRM are these two companies owned by Otiko.

I'm surprised this ticker hasn't been suspended.



icon url

zombywolf

05/21/18 9:32 AM

#37477 RE: SchlumpyStock-Picker #37405

I dont know Schlump, this is getting old.

The spending this company does issuing shares and diluting is mind boggling for what they produce. Even Chris takes $240k in stock for compensation, and produces LESS this Q, than the same time last year.
Revenues for 1Q 2018 were less than half the 4Q 2017-where is the growth from all the pumped deals? This company had better hire a monster CFO fast. Chris is worthless running this company. He needs to stay on the product development and marketing ends, and let a strong financial guy run things.